 Daniel Frank
Concepts (811)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 41 | 2024 | 763 | 5.790 |
Why?
| | Gastrointestinal Microbiome | 48 | 2025 | 696 | 5.420 |
Why?
| | Rhinitis | 15 | 2022 | 158 | 4.870 |
Why?
| | Sinusitis | 17 | 2023 | 221 | 4.850 |
Why?
| | RNA, Ribosomal, 16S | 49 | 2024 | 544 | 3.220 |
Why?
| | Bacteria | 34 | 2023 | 858 | 3.200 |
Why?
| | Metagenome | 15 | 2019 | 147 | 3.140 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 80 | 2.370 |
Why?
| | Intestines | 15 | 2022 | 359 | 2.220 |
Why?
| | Dysbiosis | 18 | 2025 | 180 | 2.160 |
Why?
| | Otitis Media | 8 | 2025 | 165 | 2.150 |
Why?
| | Feces | 25 | 2025 | 479 | 1.960 |
Why?
| | Intestinal Mucosa | 20 | 2025 | 621 | 1.710 |
Why?
| | RNA, Bacterial | 12 | 2018 | 186 | 1.590 |
Why?
| | Nasal Polyps | 5 | 2021 | 59 | 1.480 |
Why?
| | Nose | 4 | 2018 | 68 | 1.430 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 452 | 1.350 |
Why?
| | Nasal Cavity | 6 | 2023 | 51 | 1.320 |
Why?
| | Ileum | 5 | 2020 | 119 | 1.230 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 812 | 1.200 |
Why?
| | Bacteremia | 6 | 2018 | 209 | 1.190 |
Why?
| | Phylogeny | 25 | 2020 | 898 | 1.140 |
Why?
| | Crohn Disease | 6 | 2020 | 242 | 1.140 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 194 | 1.070 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 402 | 1.050 |
Why?
| | Chronic Disease | 17 | 2022 | 1790 | 0.990 |
Why?
| | HIV Infections | 15 | 2025 | 2830 | 0.940 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 33 | 0.900 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 44 | 0.880 |
Why?
| | Clostridium Infections | 4 | 2018 | 71 | 0.840 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 41 | 0.840 |
Why?
| | Colon | 9 | 2025 | 280 | 0.830 |
Why?
| | Infant Nutritional Physiological Phenomena | 4 | 2025 | 144 | 0.820 |
Why?
| | Humans | 140 | 2025 | 137514 | 0.820 |
Why?
| | Nasopharynx | 5 | 2024 | 75 | 0.800 |
Why?
| | Endoribonucleases | 8 | 2002 | 80 | 0.800 |
Why?
| | Biodiversity | 13 | 2020 | 405 | 0.780 |
Why?
| | Breast Feeding | 7 | 2025 | 439 | 0.780 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.770 |
Why?
| | Cholesteatoma | 1 | 2022 | 11 | 0.770 |
Why?
| | Bacterial Infections | 3 | 2015 | 251 | 0.760 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 351 | 0.750 |
Why?
| | Inflammation Mediators | 3 | 2023 | 514 | 0.740 |
Why?
| | RNA, Catalytic | 7 | 2001 | 186 | 0.730 |
Why?
| | Database Management Systems | 2 | 2013 | 51 | 0.710 |
Why?
| | Drinking Water | 1 | 2022 | 83 | 0.700 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.690 |
Why?
| | Inflammation | 13 | 2025 | 2837 | 0.680 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.680 |
Why?
| | Male | 72 | 2025 | 67718 | 0.680 |
Why?
| | User-Computer Interface | 2 | 2013 | 159 | 0.670 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 108 | 0.670 |
Why?
| | Female | 81 | 2025 | 73162 | 0.660 |
Why?
| | Molecular Sequence Data | 27 | 2015 | 2901 | 0.660 |
Why?
| | Software | 3 | 2021 | 670 | 0.630 |
Why?
| | Diet | 9 | 2025 | 1273 | 0.630 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 139 | 0.630 |
Why?
| | Polymerase Chain Reaction | 10 | 2018 | 1061 | 0.620 |
Why?
| | Burns | 4 | 2025 | 323 | 0.620 |
Why?
| | Infant Food | 2 | 2025 | 65 | 0.620 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.610 |
Why?
| | Animals | 56 | 2025 | 37011 | 0.590 |
Why?
| | HIV-1 | 8 | 2024 | 863 | 0.590 |
Why?
| | Adult | 48 | 2025 | 37821 | 0.590 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 135 | 0.580 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 164 | 0.570 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 451 | 0.570 |
Why?
| | Iron | 3 | 2017 | 313 | 0.570 |
Why?
| | Genes, rRNA | 3 | 2015 | 41 | 0.560 |
Why?
| | Middle Aged | 41 | 2025 | 33355 | 0.540 |
Why?
| | Fatty Liver | 2 | 2021 | 242 | 0.540 |
Why?
| | Vagina | 5 | 2016 | 186 | 0.530 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 147 | 0.520 |
Why?
| | Butyrates | 3 | 2024 | 61 | 0.520 |
Why?
| | Membrane Proteins | 3 | 2021 | 1167 | 0.510 |
Why?
| | Pharynx | 1 | 2016 | 58 | 0.510 |
Why?
| | Mice | 30 | 2025 | 17843 | 0.510 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 617 | 0.500 |
Why?
| | Nose Diseases | 1 | 2016 | 13 | 0.500 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 17 | 0.500 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 278 | 0.500 |
Why?
| | Case-Control Studies | 15 | 2020 | 3546 | 0.490 |
Why?
| | Base Sequence | 18 | 2015 | 2180 | 0.480 |
Why?
| | Biofilms | 5 | 2016 | 262 | 0.480 |
Why?
| | Cross-Sectional Studies | 16 | 2023 | 5427 | 0.480 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 147 | 0.470 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 67 | 0.470 |
Why?
| | Immunity, Innate | 4 | 2019 | 832 | 0.460 |
Why?
| | Food | 2 | 2020 | 159 | 0.460 |
Why?
| | Endotoxemia | 2 | 2014 | 86 | 0.460 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 152 | 0.440 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 49 | 0.420 |
Why?
| | Genome, Bacterial | 4 | 2016 | 142 | 0.420 |
Why?
| | Computer Graphics | 1 | 2013 | 42 | 0.420 |
Why?
| | Lactobacillus | 4 | 2022 | 29 | 0.410 |
Why?
| | Hippocampus | 1 | 2018 | 903 | 0.410 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 195 | 0.410 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 97 | 0.410 |
Why?
| | Lipid Metabolism | 2 | 2020 | 511 | 0.400 |
Why?
| | Iron, Dietary | 1 | 2013 | 21 | 0.400 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 367 | 0.400 |
Why?
| | Immunoglobulin A | 4 | 2022 | 210 | 0.400 |
Why?
| | Ear, Middle | 6 | 2025 | 93 | 0.390 |
Why?
| | Bacterial Load | 1 | 2012 | 68 | 0.390 |
Why?
| | Liver | 4 | 2020 | 1940 | 0.390 |
Why?
| | Colitis | 4 | 2025 | 265 | 0.390 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5792 | 0.390 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 236 | 0.390 |
Why?
| | Genitalia, Female | 1 | 2012 | 38 | 0.380 |
Why?
| | Probiotics | 5 | 2018 | 53 | 0.380 |
Why?
| | Diet, High-Fat | 3 | 2019 | 248 | 0.380 |
Why?
| | Smoking | 2 | 2020 | 1639 | 0.380 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 210 | 0.370 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1800 | 0.360 |
Why?
| | Genomics | 5 | 2020 | 793 | 0.350 |
Why?
| | Alcohol Drinking | 3 | 2024 | 824 | 0.350 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2012 | 389 | 0.350 |
Why?
| | Livestock | 1 | 2010 | 9 | 0.350 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 24 | 0.340 |
Why?
| | Isosorbide Dinitrate | 1 | 2010 | 4 | 0.340 |
Why?
| | Obesity | 7 | 2023 | 2974 | 0.340 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 182 | 0.340 |
Why?
| | Hydralazine | 1 | 2010 | 5 | 0.340 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 9 | 0.340 |
Why?
| | Asthma | 2 | 2015 | 2290 | 0.330 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.330 |
Why?
| | DNA Primers | 3 | 2009 | 514 | 0.330 |
Why?
| | Stress, Psychological | 1 | 2018 | 1115 | 0.330 |
Why?
| | Computational Biology | 3 | 2019 | 645 | 0.330 |
Why?
| | Fatty Acids, Volatile | 6 | 2024 | 58 | 0.330 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 21 | 0.330 |
Why?
| | Bacterial Translocation | 4 | 2019 | 43 | 0.330 |
Why?
| | Escherichia coli | 9 | 2017 | 815 | 0.330 |
Why?
| | Weight Loss | 3 | 2021 | 770 | 0.320 |
Why?
| | Agriculture | 1 | 2010 | 102 | 0.320 |
Why?
| | Genome | 2 | 2009 | 292 | 0.320 |
Why?
| | Alcohol-Related Disorders | 2 | 2008 | 124 | 0.320 |
Why?
| | Fluoroquinolones | 1 | 2009 | 49 | 0.320 |
Why?
| | Catheterization | 2 | 2009 | 179 | 0.320 |
Why?
| | Infant | 17 | 2025 | 9467 | 0.310 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 37 | 0.310 |
Why?
| | Corynebacterium | 4 | 2022 | 49 | 0.300 |
Why?
| | Wound Infection | 1 | 2009 | 33 | 0.300 |
Why?
| | Aged | 19 | 2023 | 23798 | 0.300 |
Why?
| | Behavior Therapy | 2 | 2021 | 262 | 0.300 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 2 | 0.300 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1163 | 0.290 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4295 | 0.290 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 886 | 0.290 |
Why?
| | Confidentiality | 1 | 2008 | 71 | 0.290 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.290 |
Why?
| | Seafood | 2 | 2025 | 28 | 0.290 |
Why?
| | Milk, Human | 4 | 2023 | 158 | 0.290 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 15 | 0.280 |
Why?
| | Transcriptome | 5 | 2021 | 974 | 0.280 |
Why?
| | DNA, Bacterial | 6 | 2017 | 336 | 0.280 |
Why?
| | Pedigree | 4 | 2025 | 514 | 0.280 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 176 | 0.280 |
Why?
| | Video Recording | 1 | 2008 | 184 | 0.280 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 38 | 0.280 |
Why?
| | Pneumonia | 2 | 2025 | 638 | 0.270 |
Why?
| | Genes, Bacterial | 5 | 2018 | 165 | 0.270 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 85 | 0.270 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 316 | 0.270 |
Why?
| | Physicians, Primary Care | 1 | 2010 | 236 | 0.270 |
Why?
| | Congresses as Topic | 1 | 2008 | 233 | 0.270 |
Why?
| | RNA, Transfer | 3 | 1998 | 135 | 0.270 |
Why?
| | Homeostasis | 5 | 2020 | 622 | 0.260 |
Why?
| | Perilipin-2 | 2 | 2017 | 41 | 0.260 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 720 | 0.250 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 59 | 0.250 |
Why?
| | Genotype | 4 | 2019 | 1920 | 0.250 |
Why?
| | Carrier Proteins | 1 | 2010 | 770 | 0.250 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3708 | 0.250 |
Why?
| | DNA, Ribosomal | 7 | 2017 | 86 | 0.250 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1150 | 0.250 |
Why?
| | Dietary Supplements | 3 | 2019 | 563 | 0.250 |
Why?
| | Blueberry Plants | 1 | 2025 | 7 | 0.240 |
Why?
| | Diet, Western | 3 | 2022 | 81 | 0.240 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2420 | 0.240 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 92 | 0.240 |
Why?
| | Biomarkers | 10 | 2025 | 4172 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Public Health | 1 | 2010 | 579 | 0.240 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 552 | 0.240 |
Why?
| | Neoplasms | 2 | 2018 | 2666 | 0.240 |
Why?
| | Research | 1 | 2008 | 446 | 0.230 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 601 | 0.230 |
Why?
| | Attitude of Health Personnel | 2 | 2010 | 1169 | 0.230 |
Why?
| | Phenotype | 8 | 2020 | 3205 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.230 |
Why?
| | Construction Materials | 2 | 2015 | 15 | 0.230 |
Why?
| | Pentanols | 1 | 2024 | 5 | 0.230 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 169 | 0.230 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 200 | 0.220 |
Why?
| | Palatine Tonsil | 1 | 2024 | 48 | 0.220 |
Why?
| | Lyases | 1 | 2024 | 14 | 0.220 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 400 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 538 | 0.220 |
Why?
| | Cohort Studies | 7 | 2022 | 5730 | 0.220 |
Why?
| | Air Microbiology | 2 | 2015 | 46 | 0.220 |
Why?
| | Th17 Cells | 1 | 2025 | 109 | 0.220 |
Why?
| | Glycerophospholipids | 1 | 2024 | 34 | 0.220 |
Why?
| | Infant Formula | 2 | 2023 | 75 | 0.220 |
Why?
| | Adolescent | 14 | 2024 | 21555 | 0.220 |
Why?
| | Young Adult | 13 | 2024 | 13243 | 0.210 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 167 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 116 | 0.210 |
Why?
| | Pregnancy | 11 | 2025 | 6745 | 0.210 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 30 | 0.210 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 99 | 0.210 |
Why?
| | RNA Splicing | 3 | 1995 | 268 | 0.200 |
Why?
| | Ear Canal | 1 | 2003 | 15 | 0.200 |
Why?
| | RNA, Fungal | 5 | 2002 | 72 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2025 | 227 | 0.200 |
Why?
| | Species Specificity | 4 | 2020 | 593 | 0.200 |
Why?
| | Ribonuclease P | 7 | 2001 | 22 | 0.200 |
Why?
| | Mass Screening | 2 | 2008 | 1264 | 0.200 |
Why?
| | Sepsis | 2 | 2023 | 611 | 0.200 |
Why?
| | Gene Ontology | 1 | 2022 | 53 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.200 |
Why?
| | Mice, Knockout | 6 | 2025 | 3020 | 0.200 |
Why?
| | Fungal Proteins | 2 | 2000 | 134 | 0.200 |
Why?
| | Olfaction Disorders | 1 | 2023 | 66 | 0.190 |
Why?
| | Disease Susceptibility | 3 | 2020 | 344 | 0.190 |
Why?
| | Genetic Variation | 4 | 2018 | 986 | 0.190 |
Why?
| | Hypersensitivity | 1 | 2025 | 256 | 0.190 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 10 | 0.190 |
Why?
| | Mycobacterium | 1 | 2023 | 109 | 0.190 |
Why?
| | Exome | 2 | 2020 | 231 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 392 | 0.190 |
Why?
| | Immunity | 2 | 2014 | 145 | 0.190 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 113 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 1092 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 498 | 0.180 |
Why?
| | Child, Preschool | 10 | 2025 | 11097 | 0.180 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 14 | 0.180 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 56 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 42 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 222 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 194 | 0.180 |
Why?
| | Genes, Fungal | 4 | 2000 | 53 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.180 |
Why?
| | Child | 12 | 2025 | 22037 | 0.180 |
Why?
| | Nutritional Status | 2 | 2014 | 344 | 0.170 |
Why?
| | Health | 2 | 2012 | 84 | 0.170 |
Why?
| | Ascomycota | 1 | 2000 | 32 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 30 | 0.170 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.170 |
Why?
| | Islets of Langerhans | 3 | 2015 | 803 | 0.170 |
Why?
| | Firmicutes | 2 | 2021 | 19 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Mice, Nude | 1 | 2022 | 696 | 0.170 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.170 |
Why?
| | Mouth | 1 | 2020 | 86 | 0.170 |
Why?
| | Carcinogenesis | 1 | 2022 | 220 | 0.170 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 291 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 562 | 0.170 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.160 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.160 |
Why?
| | Aged, 80 and over | 6 | 2021 | 7593 | 0.160 |
Why?
| | Body Mass Index | 5 | 2020 | 2369 | 0.160 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 117 | 0.160 |
Why?
| | Vascular Remodeling | 1 | 2021 | 190 | 0.160 |
Why?
| | Double-Blind Method | 4 | 2025 | 1987 | 0.160 |
Why?
| | Autoimmunity | 3 | 2015 | 907 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 21 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 10 | 0.160 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 54 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2025 | 6059 | 0.160 |
Why?
| | Surveys and Questionnaires | 3 | 2009 | 5772 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 41 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 175 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 5 | 0.150 |
Why?
| | Restraint, Physical | 1 | 2018 | 72 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 284 | 0.150 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 360 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2193 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 338 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Microbiological Techniques | 2 | 2016 | 30 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 126 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2113 | 0.140 |
Why?
| | Rats | 8 | 2023 | 5676 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 106 | 0.140 |
Why?
| | Random Allocation | 1 | 2018 | 357 | 0.140 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 120 | 0.140 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 23 | 0.140 |
Why?
| | Ethanol | 1 | 2022 | 608 | 0.140 |
Why?
| | Evolution, Molecular | 2 | 2018 | 488 | 0.140 |
Why?
| | Immunoglobulin D | 1 | 2017 | 30 | 0.140 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.140 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 7 | 0.140 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 179 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 2018 | 123 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2018 | 105 | 0.140 |
Why?
| | Cytokines | 5 | 2025 | 2095 | 0.140 |
Why?
| | Birth Weight | 1 | 2020 | 516 | 0.140 |
Why?
| | Lung | 4 | 2022 | 4066 | 0.140 |
Why?
| | Prospective Studies | 4 | 2020 | 7598 | 0.140 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 43 | 0.130 |
Why?
| | Water Microbiology | 3 | 2016 | 85 | 0.130 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 99 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Ceftriaxone | 1 | 2016 | 20 | 0.130 |
Why?
| | Metals | 1 | 1997 | 136 | 0.130 |
Why?
| | Micronutrients | 1 | 2017 | 95 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 492 | 0.130 |
Why?
| | Autoantibodies | 3 | 2022 | 1501 | 0.130 |
Why?
| | beta-Lactamases | 1 | 2016 | 47 | 0.130 |
Why?
| | Gene Expression | 2 | 2018 | 1505 | 0.130 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.130 |
Why?
| | Metabolome | 1 | 2020 | 350 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 68 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 2016 | 19 | 0.130 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 51 | 0.130 |
Why?
| | Salmonella Infections | 1 | 2016 | 56 | 0.130 |
Why?
| | Vitamin E | 1 | 2016 | 122 | 0.130 |
Why?
| | Bacillus | 1 | 2015 | 15 | 0.120 |
Why?
| | Binding Sites | 6 | 1998 | 1310 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 10 | 0.120 |
Why?
| | Cholesterol | 3 | 2023 | 413 | 0.120 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 131 | 0.120 |
Why?
| | Gelatin | 1 | 2016 | 50 | 0.120 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.120 |
Why?
| | Symbiosis | 2 | 2017 | 80 | 0.120 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 658 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 79 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 301 | 0.120 |
Why?
| | Interleukin-6 | 2 | 2017 | 778 | 0.120 |
Why?
| | RNA, Messenger | 4 | 2018 | 2838 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.120 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 38 | 0.120 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 23 | 0.120 |
Why?
| | Lymph | 1 | 2015 | 32 | 0.120 |
Why?
| | Catalase | 1 | 2015 | 131 | 0.120 |
Why?
| | Metagenomics | 2 | 2019 | 167 | 0.120 |
Why?
| | Hospitalization | 3 | 2018 | 2197 | 0.120 |
Why?
| | Thrombophilia | 1 | 2016 | 85 | 0.120 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 61 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 249 | 0.120 |
Why?
| | Hysterectomy | 1 | 2016 | 128 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 34 | 0.120 |
Why?
| | Thrombin | 1 | 2016 | 152 | 0.120 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 65 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 83 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 182 | 0.120 |
Why?
| | Carrier State | 1 | 2015 | 65 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 185 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2039 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 152 | 0.120 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 95 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 24 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 51 | 0.110 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 99 | 0.110 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 111 | 0.110 |
Why?
| | Physical Exertion | 1 | 2015 | 212 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 228 | 0.110 |
Why?
| | Gentamicins | 1 | 2015 | 54 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 233 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 117 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2015 | 125 | 0.110 |
Why?
| | Biota | 1 | 2014 | 33 | 0.110 |
Why?
| | Bifidobacterium | 3 | 2022 | 21 | 0.110 |
Why?
| | Genetics, Medical | 2 | 2011 | 26 | 0.110 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 11 | 0.110 |
Why?
| | Maternal Welfare | 1 | 2014 | 21 | 0.110 |
Why?
| | Adiposity | 2 | 2018 | 517 | 0.110 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 1035 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1108 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 616 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 608 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 145 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 44 | 0.110 |
Why?
| | Body Weight | 2 | 2015 | 973 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 974 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1042 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 33 | 0.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 59 | 0.110 |
Why?
| | Preconception Care | 1 | 2014 | 43 | 0.110 |
Why?
| | Nutrition Assessment | 1 | 2014 | 90 | 0.110 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 168 | 0.100 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 24 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 799 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 218 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 64 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 592 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 118 | 0.100 |
Why?
| | Drug Combinations | 2 | 2012 | 344 | 0.100 |
Why?
| | Zinc Fingers | 1 | 1992 | 50 | 0.100 |
Why?
| | Burkina Faso | 1 | 2012 | 7 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 577 | 0.100 |
Why?
| | Consensus | 1 | 2016 | 685 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 32 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 623 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 267 | 0.090 |
Why?
| | Aerosols | 1 | 2013 | 176 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 64 | 0.090 |
Why?
| | Skin | 1 | 2016 | 751 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 139 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 288 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 746 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2018 | 889 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 166 | 0.090 |
Why?
| | Influenza Vaccines | 1 | 2016 | 551 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 765 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 555 | 0.090 |
Why?
| | Viruses | 1 | 2012 | 112 | 0.090 |
Why?
| | Lactation | 1 | 2012 | 184 | 0.090 |
Why?
| | Nutritive Value | 1 | 2010 | 37 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 399 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 260 | 0.090 |
Why?
| | Food Safety | 1 | 2010 | 21 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1472 | 0.080 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.080 |
Why?
| | Amphotericin B | 1 | 2010 | 31 | 0.080 |
Why?
| | Bacterial Capsules | 1 | 2010 | 30 | 0.080 |
Why?
| | Insulin | 2 | 2022 | 2398 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1903 | 0.080 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 30 | 0.080 |
Why?
| | Urinary Catheterization | 1 | 2009 | 25 | 0.080 |
Why?
| | Risk Factors | 4 | 2018 | 10356 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 83 | 0.080 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 77 | 0.080 |
Why?
| | Cluster Analysis | 3 | 2017 | 502 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2018 | 10821 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1428 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 83 | 0.080 |
Why?
| | Montana | 1 | 2009 | 20 | 0.080 |
Why?
| | Mississippi | 1 | 2009 | 21 | 0.080 |
Why?
| | Biomass | 1 | 2009 | 129 | 0.080 |
Why?
| | Prostatectomy | 1 | 2009 | 104 | 0.080 |
Why?
| | Sequence Alignment | 3 | 2001 | 345 | 0.080 |
Why?
| | Fatty Acids | 3 | 2022 | 445 | 0.080 |
Why?
| | Prevalence | 2 | 2014 | 2719 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2022 | 15628 | 0.080 |
Why?
| | Permeability | 2 | 2022 | 162 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2017 | 1185 | 0.080 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 143 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 667 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 917 | 0.080 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 114 | 0.070 |
Why?
| | Systems Integration | 1 | 2008 | 37 | 0.070 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 327 | 0.070 |
Why?
| | Environment | 1 | 2010 | 362 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 1950 | 0.070 |
Why?
| | Housing | 1 | 2009 | 146 | 0.070 |
Why?
| | Down-Regulation | 2 | 2024 | 658 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2521 | 0.070 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 75 | 0.070 |
Why?
| | RNA Precursors | 4 | 1998 | 153 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2857 | 0.070 |
Why?
| | Ecosystem | 2 | 2010 | 592 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2615 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 46 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 118 | 0.070 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 167 | 0.070 |
Why?
| | Prognosis | 2 | 2020 | 4031 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 766 | 0.070 |
Why?
| | Child Development | 1 | 2012 | 474 | 0.070 |
Why?
| | Physicians, Family | 1 | 2009 | 206 | 0.070 |
Why?
| | Focus Groups | 1 | 2010 | 512 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 238 | 0.070 |
Why?
| | Plasmids | 4 | 2016 | 363 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2010 | 354 | 0.070 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 224 | 0.070 |
Why?
| | Research Personnel | 1 | 2008 | 170 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3292 | 0.070 |
Why?
| | Indomethacin | 1 | 2006 | 81 | 0.060 |
Why?
| | Peptic Ulcer | 1 | 2006 | 20 | 0.060 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 27 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 586 | 0.060 |
Why?
| | Proteobacteria | 2 | 2017 | 15 | 0.060 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 29 | 0.060 |
Why?
| | Opportunistic Infections | 1 | 2006 | 47 | 0.060 |
Why?
| | Kenya | 2 | 2017 | 115 | 0.060 |
Why?
| | Autoantigens | 2 | 2022 | 429 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2022 | 886 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 846 | 0.060 |
Why?
| | Inpatients | 1 | 2010 | 502 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 197 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 155 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 17 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Artificial Intelligence | 1 | 2008 | 275 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 26 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 60 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1996 | 536 | 0.060 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 1105 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 668 | 0.060 |
Why?
| | Hexanols | 1 | 2024 | 4 | 0.060 |
Why?
| | Fruit | 1 | 2025 | 138 | 0.060 |
Why?
| | Oropharynx | 1 | 2024 | 46 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2005 | 318 | 0.060 |
Why?
| | Age Factors | 2 | 2025 | 3301 | 0.060 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 319 | 0.060 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 88 | 0.060 |
Why?
| | Methylamines | 1 | 2024 | 34 | 0.060 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 200 | 0.060 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 62 | 0.060 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 70 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 182 | 0.050 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 168 | 0.050 |
Why?
| | Comorbidity | 1 | 2009 | 1618 | 0.050 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 11 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 82 | 0.050 |
Why?
| | Bites and Stings | 1 | 2004 | 32 | 0.050 |
Why?
| | Zoonoses | 1 | 2004 | 31 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 54 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1776 | 0.050 |
Why?
| | Cats | 1 | 2004 | 211 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 350 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1242 | 0.050 |
Why?
| | Choline | 1 | 2024 | 131 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 566 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2501 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 120 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Gram-Negative Anaerobic Bacteria | 1 | 2002 | 2 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 596 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 10 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 851 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.050 |
Why?
| | Pilot Projects | 2 | 2018 | 1703 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 462 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 55 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 229 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 48 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 183 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 317 | 0.050 |
Why?
| | Glycerol | 1 | 2022 | 94 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 266 | 0.050 |
Why?
| | Amniotic Fluid | 1 | 2002 | 95 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1702 | 0.050 |
Why?
| | Smell | 1 | 2023 | 146 | 0.050 |
Why?
| | Japan | 1 | 2021 | 116 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 377 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 49 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 202 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 447 | 0.040 |
Why?
| | Pigments, Biological | 1 | 2001 | 17 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 665 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2021 | 88 | 0.040 |
Why?
| | RNA, Archaeal | 1 | 2001 | 16 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 407 | 0.040 |
Why?
| | Systole | 1 | 2021 | 191 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 143 | 0.040 |
Why?
| | Tight Junctions | 1 | 2021 | 77 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 21 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 145 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 73 | 0.040 |
Why?
| | Macrophages | 2 | 2021 | 1548 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5139 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 254 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 86 | 0.040 |
Why?
| | DNA, Fungal | 1 | 2000 | 79 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 363 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 94 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 105 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 395 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 456 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2021 | 121 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1740 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 68 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 227 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 552 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 275 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 77 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 117 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 165 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 361 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 155 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 180 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 133 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6817 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 319 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 3964 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 385 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 34 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 242 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 664 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.040 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 123 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.040 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 3 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 188 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 53 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 3 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 124 | 0.040 |
Why?
| | Acute Disease | 2 | 2016 | 1008 | 0.040 |
Why?
| | Magnesium | 1 | 1998 | 159 | 0.040 |
Why?
| | Syndecan-1 | 1 | 2017 | 38 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 595 | 0.030 |
Why?
| | Powders | 1 | 2017 | 43 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 561 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 82 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 71 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 164 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 457 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 480 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1018 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 79 | 0.030 |
Why?
| | Prophages | 1 | 2016 | 7 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1271 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 66 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 89 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 30 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 214 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 38 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 814 | 0.030 |
Why?
| | Heart Failure | 1 | 2010 | 2222 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 117 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 65 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 22 | 0.030 |
Why?
| | Primary Health Care | 1 | 2007 | 1756 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 792 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 269 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 5 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 496 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2838 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 23 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 288 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 29 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 106 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 816 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 780 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 734 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 63 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 180 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 353 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 26 | 0.030 |
Why?
| | North America | 1 | 2016 | 313 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 48 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 624 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 14 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 87 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 362 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 59 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 31 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 516 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 21 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1060 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 2 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 89 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 171 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 5 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 417 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 30 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 679 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 47 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 493 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 76 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 99 | 0.030 |
Why?
| | Methane | 1 | 2014 | 51 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2066 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 282 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 32 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 63 | 0.030 |
Why?
| | Geography | 1 | 2014 | 197 | 0.030 |
Why?
| | Models, Animal | 1 | 2015 | 387 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 24 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 347 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 607 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 182 | 0.030 |
Why?
| | Sequence Deletion | 1 | 1994 | 183 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 270 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 346 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 257 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 413 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 345 | 0.030 |
Why?
| | New York City | 1 | 2013 | 87 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 183 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 1992 | 15 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 546 | 0.030 |
Why?
| | Genes, Lethal | 1 | 1992 | 30 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 8 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2852 | 0.020 |
Why?
| | Staphylococcus | 1 | 2013 | 76 | 0.020 |
Why?
| | Endoscopy | 1 | 2015 | 316 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 84 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 369 | 0.020 |
Why?
| | Cattle | 2 | 2005 | 982 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1866 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 501 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 316 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 186 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1524 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 344 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 752 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 48 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 306 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 524 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 434 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 97 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 387 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2755 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 614 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 488 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1307 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 790 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 404 | 0.020 |
Why?
| | Milk | 1 | 2012 | 123 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 424 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5096 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 614 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 129 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 425 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 108 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 437 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 237 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 678 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3439 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2183 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 903 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1227 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 632 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1132 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1324 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2870 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 7 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 464 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 845 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 415 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 308 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 38 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 15 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 202 | 0.020 |
Why?
| | Clinical Medicine | 1 | 2009 | 24 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2146 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3722 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1770 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1507 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.020 |
Why?
| | Washington | 1 | 2007 | 154 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1398 | 0.020 |
Why?
| | Internal Medicine | 1 | 2009 | 254 | 0.020 |
Why?
| | RNA | 1 | 2013 | 924 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 29 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 986 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 503 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 689 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1123 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2482 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2005 | 162 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 13 | 0.010 |
Why?
| | Culture Media | 1 | 2005 | 167 | 0.010 |
Why?
| | United States | 2 | 2015 | 14696 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 555 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 304 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 142 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 122 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2557 | 0.010 |
Why?
| | Risk-Taking | 1 | 2007 | 354 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2016 | 2641 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 930 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 113 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 311 | 0.010 |
Why?
| | Psychometrics | 1 | 2007 | 723 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2007 | 539 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 2002 | 79 | 0.010 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2002 | 45 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1060 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1241 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2009 | 1312 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 53 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 521 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 191 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 67 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 25 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 53 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 182 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1679 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4206 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 487 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 27 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 46 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 85 | 0.010 |
Why?
| | Genes | 1 | 1989 | 230 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 322 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1357 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|